Pfizer Inc. news

   Watch this stock
Showing stories 11 - 20 of about 211   

Articles published

PFE 32.52 -0.08 (-0.25%)
price chart
Global Hemostats Market 2016 – Ethicon, Inc., Pfizer, Inc., Baxter ...
Global Hemostats Market 2016 - Ethicon, Inc., Pfizer, Inc., Baxter International Inc., C. R. Bard, The Medicines Company, Anika Therapeutics, Inc. By.
Pfizer, Inc. (PFE) Position Raised by Smith Chas P & Associates PA Cpas
Pfizer logo Smith Chas P & Associates PA Cpas raised its position in shares of Pfizer, Inc. (NYSE:PFE) by 2.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission.
The Growth Forecast For Pfizer, Inc. (NYSE:PFE)
Wall Street renowned brokerages following Pfizer, Inc. (NYSE:PFE) have now given a mean price target of $38.153 on its stock.
4 Reasons Why Pfizer Inc. Stock (PFE) Could be a Great Pick in 2017
Pfizer Inc. (PFE) is one of the most prominent names in the pharmaceutical sector, not just for its medicines and vaccines but also for its consumer healthcare products.
Pfizer Inc. (NYSE:PFE) Analyst Opinion
Pfizer Inc. (NYSE:PFE) stock is presently standing at about $32.48 and lots of equity research firms seem to have a target price set on the stock.
Stock in Limelight: Pfizer Inc. (NYSE:PFE)  Post Registrar
Advisors Asset Management Inc. Has $57122000 Position in Pfizer, Inc. (PFE)  The Cerbat Gem
Healthcare companies reporting results in January 2017: Pfizer Inc (NYSE: PFE ...
AbbVie Inc (NYSE: ABBV) is expected to report its earnings between January 27th to Jan 31st 2017. For the current quarter the analysts' are expecting that the company will post the earnings per share at an average of $1.2. The analysts have also ...
Pfizer Inc. (NYSE:PFE) added about 4.6 percent in value since last earnings
Pfizer Inc. (NYSE:PFE) is projected to declare fiscal fourth quarter financial results right before the stock market's official open on January 31, 2017.
Large Buying Action and Inflow of Money Witnessed in Pfizer, Inc.
Pfizer, Inc. (NYSE:PFE) saw its share price trade relatively negative in the recent trading session. The share price was last updated to $33.48 with a loss of -0.01 points or -0.01%.
Pfizer Inc. (PFE) Earns Buy Rating from Credit Suisse Group AG
Pfizer Inc. logo Credit Suisse Group AG reaffirmed their buy rating on shares of Pfizer Inc. (NYSE:PFE) in a research note published on Tuesday morning.
Spark Gets A Check From Pfizer And A Downgrade From Vetr
The Vetr crowd downgraded their rating for Spark Therapeutics Inc (NASDAQ: ONCE) on Thursday, from 4.5 stars (Strong Buy), issued 519 days ago, to 4 stars (Buy).